USING PHARMACOECONOMIC MODELLING TO DETERMINE VALUE-BASED PRICING FOR NEW MEDICINES
| Autor: | I. S. KRYSANOV, V. Yu. ERMAKOVA, A. V. ZABOROVSKY, K. G. GUREVICH |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2017 |
| Předmět: | |
| Zdroj: | Кубанский научный медицинский вестник, Vol 1, Iss 1, Pp 78-83 (2017) |
| Druh dokumentu: | article |
| ISSN: | 1608-6228 2541-9544 |
| DOI: | 10.25207/1608-6228-2017-1-78-83 |
| Popis: | Purpose: to carry out pharmacoeconomic modeling for an early economic evaluation of the generic pegylated liposomal doxorubicin (PLD) drug.Materials and methods: a Markov model and Decision tree model were developed to simulate and to compare the costs and effects of new generic PLD versus doxorubicin. Using the threshold criteria for economic value (willingness to pay threshold (WTP) for Russia), we determine value-based pricing for new generic PLD.Results: pharmacoeconomic modeling can be used for an early economic evaluation of new medicines to determine value-based pricing for new pharmaceuticals and its financial impact on Russian health care system. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|